Related Experiment Video
Updated: Jun 25, 2026
09:37
Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
Cardiolipin remodeling in the heart
Genevieve C Sparagna1, Edward J Lesnefsky
1Department of Integrative Physiology, University of Colorado Cardiovascular Institute, University of Colorado at Boulder, Boulder, CO, USA.
Journal of Cardiovascular Pharmacology
|March 12, 2009
Summary
Cardiolipin (CL), vital for heart function, loses linoleic acid in cardiac disorders. Pathological remodeling alters CL, but dietary changes may restore its beneficial form and improve heart health.
Area of Science:
- Mitochondrial biochemistry
- Cardiovascular research
- Lipid metabolism
Background:
- Cardiolipin (CL) is a crucial mitochondrial phospholipid essential for inner mitochondrial membrane protein function and electron transport chain integrity.
- In the heart, functional CL is rich in linoleic acid, and its depletion is linked to cardiac disorders like heart failure, diabetes, and Barth syndrome.
Purpose of the Study:
- To investigate the role of cardiolipin remodeling in cardiac pathology.
- To explore how pathological remodeling of CL contributes to heart dysfunction.
- To assess the potential of dietary interventions in restoring CL composition and improving cardiac function.
Main Methods:
- The study focuses on the molecular mechanisms of cardiolipin remodeling, including normal and pathological pathways.
- It examines the impact of oxidative stress on cardiolipin modification.
- The research explores how dietary interventions can influence cardiolipin remodeling.
Main Results:
- Pathological remodeling can lead to the substitution of linoleic acid with other fatty acids (e.g., arachidonic, docosahexaenoic acid) on cardiolipin.
- This altered CL composition is associated with increased oxidative damage and cardiac dysfunction.
- Dietary interventions show promise in restoring linoleic acid-rich cardiolipin.
Conclusions:
- Changes in cardiolipin composition due to pathological remodeling are implicated in the development of cardiac pathology.
- Restoring linoleic acid content in cardiolipin through dietary strategies may offer a therapeutic approach for cardiac disorders.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:25Lipid Catabolism
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...